Heart pump study for planned high-risk heart stent procedures
Part of Heart & circulation clinical trials.
This study looks at using a temporary heart pump called Impella ECP during planned high-risk heart stent procedures (PCI). It may help doctors support the heart more safely while placing the stents.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 90 years old.
- You can understand and sign the study consent form.
- Your heart team has decided you need an urgent or elective high-risk heart stent procedure (not an emergency).
- Your aortic valve and blood vessels are suitable for the pump to be placed (no blockage/shape problems; no significant valve disease).
- You do not have certain bleeding/clotting risks or medication limits (for example, cannot take heparin or aspirin if needed).
- You are not on dialysis, not pregnant, and you don’t have certain infection or recent COVID-19 history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
This study tests a new device to help people with high-risk blockages in their heart arteries during a stent procedure. It compares the new device to standard treatment to see if it is safe and effective.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This trial tests whether a small heart-support device called Impella CP helps protect your heart during complex coronary angioplasty (a procedure to open blocked heart arteries). You may qualify if you have weak heart function and specific patterns of blocked arteries that make the procedure higher risk.
This study looks at how well the Impella CP heart pump works for people who have a severe heart attack that causes their heart to pump too weakly to keep blood flowing to their body. It's a registry that follows your care to improve best practices.
This study reviews how well people tolerated the Impella heart pump during cardiogenic shock and what complications occurred. It looks at past cases from 2010 to 2022 to help doctors understand the safety of this device.
Hear when a new High-Risk Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.